AKT1 and metabolic dysfunction-associated steatotic liver disease: In recent years, protein kinases, including mTOR, MAPK, PKC, PI3K/Akt, and ErbB, were shown to govern most of the pathological pathways in NAFLD and regulate both inflammation and hepatic gluco- and liponeogenesis [21] (Figure 2).